CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2023

Jun 5, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2023-05-25

Reporting Person: Thompson Tamar (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase Common Stock	$11.60	2030-05-25	Common Stock (40000)		Direct

Footnotes

F1: Options will vest in three equal tranches on May 25, 2024, 2025 and 2026.